Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64
United States Fiscal year ends December CIK 0001655759 Results filed 3 Nov 2026

What the insiders did No buying or selling

By person

15 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
John G Houston
Director
—
—
—
1,122,183
$9.16M
+8.2%
Randy Teel
President and CEO
—
—
—
285,009
$2.33M
+80.1%
Noah Berkowitz
Chief Medical Officer
—
—
—
191,395
$1.56M
+201.6%
Andrew Saik
Chief Financial Officer
—
—
—
187,432
$1.53M
+205.2%
Angela M Cacace
Chief Scientific Officer
—
—
—
180,390
$1.47M
+234.5%
Ian Taylor
President, R&D
—
—
—
159,121
$1.30M
+7.9%
Briggs Morrison
Director
—
—
—
111,548
$910.12K
+271.9%
Edward Moore Kennedy Jr.
Director
—
—
—
54,957
$448.39K
+134.8%
Leslie Norwalk V
Director
—
—
—
41,572
$339.19K
+314.9%
Everett Cunningham
Director
—
—
—
41,572
$339.19K
+314.9%
Alsup Laurie Smaldone
Director
—
—
—
41,572
$339.19K
+314.9%
Linda Bain
Director
—
—
—
41,572
$339.19K
+314.9%
David K Loomis
VP, Chief Accounting Officer
—
—
—
40,193
$327.93K
+262.7%
Sunil Agarwal
Director
—
—
—
30,166
$246.12K
+113.3%
John D Young
Director
—
—
—
26,045
$212.50K
+159.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.